Leslie Cooper Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Filing of 2020 Year-End Financial Statements and MD&A
Cardiol Therapeutics Inc. (
a clinical-stage biotechnology company
focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, today filed its audited Financial Statements and Management s Discussion and Analysis for the year ended December 31, 2020. Both are available under the Company s profile on SEDAR at www.sedar.com and on the Company s website at www.cardiolrx.com.
David Elsley, President and Chief Executive Officer of Cardiol, commented: 2020 was a very exciting year for Cardiol Therapeutics. We made extraordinary progress in our research and clinical development programs, while significantly strengthening our financial position. We are particularly excited about the progress made across our research and development programs supporting the development of CardiolRx, our pharmaceutically produced extra- ....

United States , Guilherme Oliveira , Carsten Tsch , Weldon Smith , David Elsley , Matthias Friedrich , Wilson Tang , Trevor Burns , Andrew Hamer , Peter Liu , Arvind Bhimaraj , Barry Trachtenberg , Heart Failure Research , Data Safety Monitoring Committee , Cardiol Therapeutics Inc , Shoppers Drug Mart Inc , Department Of Cardiovascular Medicine , University Of Pittsburgh , University Of Ottawa Heart Institute , Leslie Cooper Co , Mcgill University Health Centre , York Stock Exchange , Company Phase , Mayo Clinic Enterprise Department Of Cardiovascular Medicine , Steering Committee , American College Of Cardiology ,